HRP20110024T1 - Antibakterijski derivati kvinolina - Google Patents

Antibakterijski derivati kvinolina Download PDF

Info

Publication number
HRP20110024T1
HRP20110024T1 HR20110024T HRP20110024T HRP20110024T1 HR P20110024 T1 HRP20110024 T1 HR P20110024T1 HR 20110024 T HR20110024 T HR 20110024T HR P20110024 T HRP20110024 T HR P20110024T HR P20110024 T1 HRP20110024 T1 HR P20110024T1
Authority
HR
Croatia
Prior art keywords
alkyl
aryl
het
mono
compound according
Prior art date
Application number
HR20110024T
Other languages
English (en)
Croatian (hr)
Inventor
Emile Georges Guillemont J�r�me
Dorange Ismet
Francis Alain Lan�ois David
Manuel Villalgordo-Soto Jos�
Ren� Ferdinand Simonnet Yvan
Madeleine Simone Motte Magali
Jozef Lodewijk Marcel Andries Koenraad
Koul Anil
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38048032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20110024(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of HRP20110024T1 publication Critical patent/HRP20110024T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20110024T 2006-12-06 2007-12-04 Antibakterijski derivati kvinolina HRP20110024T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06125545 2006-12-06
PCT/EP2007/063319 WO2008068272A2 (en) 2006-12-06 2007-12-04 Antibacterial quinoline derivatives

Publications (1)

Publication Number Publication Date
HRP20110024T1 true HRP20110024T1 (hr) 2011-04-30

Family

ID=38048032

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110024T HRP20110024T1 (hr) 2006-12-06 2007-12-04 Antibakterijski derivati kvinolina

Country Status (33)

Country Link
US (1) US20100063026A1 (OSRAM)
EP (1) EP2099761B1 (OSRAM)
JP (1) JP5466013B2 (OSRAM)
KR (1) KR101553600B1 (OSRAM)
CN (1) CN101547906B (OSRAM)
AP (1) AP2477A (OSRAM)
AR (1) AR064148A1 (OSRAM)
AT (1) ATE486061T1 (OSRAM)
AU (1) AU2007328892B2 (OSRAM)
BR (1) BRPI0719915A2 (OSRAM)
CA (1) CA2668558C (OSRAM)
CL (1) CL2007003518A1 (OSRAM)
CY (1) CY1112027T1 (OSRAM)
DE (1) DE602007010182D1 (OSRAM)
DK (1) DK2099761T3 (OSRAM)
EA (1) EA016760B1 (OSRAM)
ES (1) ES2354755T3 (OSRAM)
HR (1) HRP20110024T1 (OSRAM)
IL (1) IL199082A (OSRAM)
JO (1) JO2683B1 (OSRAM)
ME (1) ME01230B (OSRAM)
MX (1) MX2009005906A (OSRAM)
MY (1) MY145940A (OSRAM)
NO (1) NO341984B1 (OSRAM)
NZ (1) NZ576862A (OSRAM)
PL (1) PL2099761T3 (OSRAM)
PT (1) PT2099761E (OSRAM)
RS (1) RS51582B (OSRAM)
SI (1) SI2099761T1 (OSRAM)
TW (1) TWI487526B (OSRAM)
UA (1) UA101307C2 (OSRAM)
WO (1) WO2008068272A2 (OSRAM)
ZA (1) ZA200903949B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2970B1 (en) * 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
US9133167B2 (en) 2012-04-27 2015-09-15 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
KR102110366B1 (ko) 2012-04-27 2020-05-14 얀센 파마슈티카 엔.브이. 항균성 퀴놀린 유도체
KR20240161147A (ko) 2022-03-14 2024-11-12 슬랩 파마슈티컬스 엘엘씨 다중 사이클릭 화합물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965572A (en) * 1996-10-28 1999-10-12 The United States Of America As Respresented By The Secretary Of The Army Methods for treating antibiotic-resistant infections
PT1527050E (pt) * 2002-07-25 2010-06-22 Janssen Pharmaceutica Nv Derivados de quinolina e sua utilização como inibidores de micobactérias
ATE444068T1 (de) * 2004-01-23 2009-10-15 Janssen Pharmaceutica Nv Chinolinderivate und ihre verwendung als mycobakterielle inhibitoren
MXPA06008596A (es) * 2004-01-29 2006-08-28 Janssen Pharmaceutica Nv Derivados de quinolina para uso como inhibidores micobacterianos.
JO2524B1 (en) * 2004-05-28 2010-03-17 جانسن فارمسيتكا ان في Use of substituted quinoline derivatives to treat drug-resistant microbial diseases
EE05394B1 (et) * 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
EE05697B1 (et) * 2005-06-08 2014-02-17 Janssen Pharmaceutica N.V. Kinoliini derivaadid kui antibakteriaalsed toimeained
CA2612614C (en) * 2005-06-28 2017-07-25 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents
JO2752B1 (en) * 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2855B1 (en) * 2005-08-03 2015-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2837B1 (en) * 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents
JO2952B1 (en) * 2005-08-03 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents

Also Published As

Publication number Publication date
AU2007328892A1 (en) 2008-06-12
ZA200903949B (en) 2010-08-25
NO341984B1 (no) 2018-03-05
DE602007010182D1 (de) 2010-12-09
BRPI0719915A2 (pt) 2014-03-04
AU2007328892B2 (en) 2013-05-16
JP5466013B2 (ja) 2014-04-09
JP2010511672A (ja) 2010-04-15
US20100063026A1 (en) 2010-03-11
CN101547906A (zh) 2009-09-30
AP2477A (en) 2012-09-27
SI2099761T1 (sl) 2011-02-28
DK2099761T3 (da) 2011-02-07
NZ576862A (en) 2012-01-12
MY145940A (en) 2012-05-31
AR064148A1 (es) 2009-03-18
CL2007003518A1 (es) 2008-07-11
RS51582B (sr) 2011-08-31
MX2009005906A (es) 2009-06-16
TWI487526B (zh) 2015-06-11
PT2099761E (pt) 2011-01-18
AP2009004873A0 (en) 2009-06-30
KR101553600B1 (ko) 2015-09-16
CA2668558A1 (en) 2008-06-12
EP2099761A2 (en) 2009-09-16
TW200831095A (en) 2008-08-01
WO2008068272A2 (en) 2008-06-12
KR20090102778A (ko) 2009-09-30
EA016760B1 (ru) 2012-07-30
CN101547906B (zh) 2014-08-06
CY1112027T1 (el) 2015-11-04
ES2354755T3 (es) 2011-03-17
EA200970537A1 (ru) 2009-10-30
EP2099761B1 (en) 2010-10-27
ME01230B (me) 2013-03-20
IL199082A (en) 2014-04-30
PL2099761T3 (pl) 2011-04-29
JO2683B1 (en) 2013-03-03
CA2668558C (en) 2016-06-07
UA101307C2 (ru) 2013-03-25
NO20092541L (no) 2009-09-02
HK1137437A1 (en) 2010-07-30
WO2008068272A3 (en) 2008-07-24
ATE486061T1 (de) 2010-11-15

Similar Documents

Publication Publication Date Title
HRP20100428T1 (hr) Antibakterijski derivati kvinolina
HRP20160585T1 (hr) Antibakterijski derivati kinolina
JP2010511667A5 (OSRAM)
JP2010511668A5 (OSRAM)
RU2009125520A (ru) Антибактериальные хинолиновые производные
HRP20090673T1 (hr) Derivati kvinolina i njihova uporaba kao mikobakterijskih inhibitora
CA2846663A1 (en) Antibacterial compounds and methods for use
HRP20131116T1 (hr) Derivati kinolina kao antibakterijska sredstva
MXPA05007671A (es) Derivados de triazina como absorbedores de uv.
EP4444429A1 (en) Raf kinase inhibitors and methods of use thereof
MX348548B (es) Derivado heterociclico y farmaceutico.
JP2010511671A5 (OSRAM)
ME01230B (me) Antibakterijski derivati kvinolina
HRP20100384T1 (hr) Antibakterijski derivati kvinolina
PH12020550761A1 (en) 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZINONE DERIVATIVE AND MEDICAL USE THEREOF
MY143605A (en) Tri-, tetra-substituted-3-aminopyrrolidine derivative
JP2010511670A5 (OSRAM)
JP2010511672A5 (OSRAM)
IL268967B (en) Azetidine derivative
AR054587A1 (es) Derivados de quinolina antibacterianos
MX2009013775A (es) Sustituto novedoso de piperidones sustituidas como inductor de hsp.
KR20240113496A (ko) Gcn2 및 perk 키나아제 억제제로서의 헤테로고리 화합물
CN119585242A (zh) Raf激酶抑制剂及其使用方法
JP2010511669A5 (OSRAM)
AR064147A1 (es) Derivados de quinolina antibacterianos